Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
|
| gptkbp:activeIngredient |
gptkb:oxytocin
|
| gptkbp:approvedBy |
1950s
|
| gptkbp:ATCCode |
gptkb:H01BB02
|
| gptkbp:contraindication |
hypersensitivity to oxytocin
significant cephalopelvic disproportion |
| gptkbp:discoveredBy |
gptkb:Sir_Henry_Hallett_Dale
|
| gptkbp:form |
solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Syntocinon
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:pregnancyCategory |
AU: A
US: N (not classified) |
| gptkbp:routeOfAdministration |
intramuscular
intravenous |
| gptkbp:sideEffect |
gptkb:uterine_hyperstimulation
nausea vomiting hypertension water intoxication |
| gptkbp:usedFor |
augmentation of labor
induction of labor postpartum hemorrhage prevention |
| gptkbp:bfsParent |
gptkb:Oxytocin
|
| gptkbp:bfsLayer |
7
|